Chemoinformaics analysis of 7-HYDROXYTRIACONTAN-5-ONE
| Molecular Weight | 452.808 | nRot | 27 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 24 |
| Exact Molecular Weight | 452.459 | nRing | 0 |
| Solubility: LogS | -3.524 | nHRing | 0 |
| Solubility: LogP | 2.408 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 92 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 91.7116 |
| nHD | 1 | BPOL | 61.0604 |
| QED | 0.64 |
| Synth | 4.984 |
| Natural Product Likeliness | 1.911 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.616 |
| Pgp-sub | 0.985 |
| HIA | 0.331 |
| CACO-2 | -4.942 |
| MDCK | 0.0000319 |
| BBB | 0.99 |
| PPB | 0.678304 |
| VDSS | 2.632 |
| FU | 0.349083 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.945 |
| CYP2c19-inh | 0.154 |
| CYP2c19-sub | 0.925 |
| CYP2c9-inh | 0.075 |
| CYP2c9-sub | 0.187 |
| CYP2d6-inh | 0.977 |
| CYP2d6-sub | 0.876 |
| CYP3a4-inh | 0.886 |
| CYP3a4-sub | 0.677 |
| CL | 6.407 |
| T12 | 0.042 |
| hERG | 0.044 |
| Ames | 0.024 |
| ROA | 0.92 |
| SkinSen | 0.041 |
| Carcinogencity | 0.842 |
| EI | 0.032 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.839 |
| Antiviral | No |
| Prediction | 0.565606 |